Price T Rowe Associates Inc Enovis Corp Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Enovis Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 38,750 shares of ENOV stock, worth $1.42 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

38,750

Previous 252,753 84.67%

Holding current value

$1.42 Million

Previous $10.9 Million 84.37%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$38.5 - $49.33 $8.24 Million - $10.6 Million	-214,003 Reduced 84.67%	38,750 $1.7 Million
Q3 2024 Nov 14, 2024	SELL	$40.57 - $48.1 $4.8 Million - $5.69 Million	-118,395 Reduced 31.9%	252,753 $10.9 Million
Q2 2024 Aug 14, 2024	SELL	$44.56 - $62.43 $444,263 - $622,427	-9,970 Reduced 2.62%	371,148 $16.8 Million
Q1 2024 May 15, 2024	BUY	$55.44 - $63.8 $9.94 Million - $11.4 Million	179,276 Added 88.82%	381,118 $23.8 Million
Q4 2023 Feb 14, 2024	BUY	$43.67 - $57.07 $7.53 Million - $9.84 Million	172,468 Added 587.15%	201,842 $11.3 Million
Q3 2023 Nov 14, 2023	BUY	$51.65 - $65.54 $121,067 - $153,625	2,344 Added 8.67%	29,374 $1.55 Million
Q2 2023 Aug 14, 2023	SELL	$52.7 - $64.12 $202,736 - $246,669	-3,847 Reduced 12.46%	27,030 $1.73 Million
Q1 2023 May 15, 2023	SELL	$49.5 - $65.92 $562,468 - $749,048	-11,363 Reduced 26.9%	30,877 $1.65 Million
Q4 2022 Feb 14, 2023	BUY	$44.83 - $57.43 $145,921 - $186,934	3,255 Added 8.35%	42,240 $2.26 Million
Q3 2022 Nov 14, 2022	SELL	$46.07 - $60.1 $277 Million - $362 Million	-6,019,178 Reduced 99.36%	38,985 $1.8 Million
Q2 2022 Aug 15, 2022	BUY	$55.0 - $70.47 $333 Million - $427 Million	6,058,163 New	6,058,163 $333 Million

Others Institutions Holding ENOV

# of Institutions

314

Shares Held

60.6M

Call Options Held

1.83M

Put Options Held

661K

View Full List

About Enovis CORP

Ticker ENOV
Exchange NYSE
Sector Industrials
Industry Specialty Industrial Machinery
Shares Outstandng 54,129,500
Market Cap $1.98B
Description
Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...

More about ENOV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Enovis Corp Transaction History